Skip to main content
Type1DiabetesTrialNet

Main navigation

  • Get Screened
  • Our Research
  • T1D Facts
  • TrialNet Locations
  • About Us
  • News & Events
  • Healthcare Providers
  • Get Involved

Utility Menu

  • Researchers
  • Publications
  • Contact Us
  • FAQs
  • Terminology
  • English
  • Español

Breadcrumb

  1. Home
  2. News & Events

TrialNet Blog

Main navigation

  • Blog
  • Events

Get Screened

Detect your risk of developing T1D. Join our #T1DFamily members on the Pathway to Prevention today!

Get Started

Research Spotlight
Research Spotlight

TrialNet Launches New Prevention Study— First to test hydroxychloroquine in T1D

A newly launched prevention study will test the drug hydroxychloroquine (HCQ) to see if it can delay or prevent early stage T1D (stage 1) from progressing to abnormal glucose tolerance (stage 2) and ultimately prevent clinical diagnosis (st

Read more
Research Spotlight
Research Spotlight

In-home test kits make TrialNet screening convenient and easy

TrialNet screening is free, quick, and now more convenient than ever. Our new in-home test kits provide everything you need to collect your or your family member’s blood sample in the comfort of your home. 

Read more
Get in Touch
  • Type 1 Diabetes TrialNet
  • Phone: 1-800-425-8361
  • MON-FRI 8am-5pm ET

Contact Us

Quick Links
  • T1D Risk Screening
  • TrialNet Prevention Studies
  • The Stages of Type 1 Diabetes
  • Frequently Asked Questions
  • For Researchers
  • Member Login
Find a Location
map

Over 100 risk screening and study locations worldwide. Find A Location

Stay Connected

Follow TrialNet for important T1D research news and updates on social media or join our mailing list.

Subscribe Now
  • Facebookfacebook
  • Twittertwitter
  • YouTubeyoutube
  • ©2018 Type 1 Diabetes TrialNet
  • Terms of Use
  • Your Privacy
  • Member Login
  • NIH
Collage of smiling children participating in TrialNet studies

Stay Connected

Get the latest news & updates from the frontline
of T1D research, right to your inbox.

No thanks, return to view